99 related articles for article (PubMed ID: 37840315)
21. Synthesis, biological evaluation, and molecular modelling of novel quinoxaline-isoxazole hybrid as anti-hyperglycemic.
Phongphane L; Mohd Radzuan SN; Abu Bakar MH; Che Omar MT; Supratman U; Harneti D; A Wahab H; Azmi MN
Comput Biol Chem; 2023 Oct; 106():107938. PubMed ID: 37542847
[TBL] [Abstract][Full Text] [Related]
22. Molecular Dynamics and Biological Evaluation of 2-chloro-7-cyclopentyl- 7H-pyrrolo[2,3-d]pyrimidine Derivatives Against Breast Cancer.
Singaram K; Marimuthu D; Baskaran S; Chinaga SK; Shanmugarajan D; Vadivel T
Comb Chem High Throughput Screen; 2017; 20(8):703-712. PubMed ID: 28738766
[TBL] [Abstract][Full Text] [Related]
23. Design, Synthesis, and Biological Evaluation of Novel Indanone Derivatives as Cholinesterase Inhibitors for Potential Use in Alzheimer's Disease.
Etemadi A; Hemmati S; Shahrivar-Gargari M; Abibiglue YT; Bavili A; Hamzeh-Mivehroud M; Dastmalchi S
Chem Biodivers; 2023 Aug; 20(8):e202300075. PubMed ID: 37458518
[TBL] [Abstract][Full Text] [Related]
24. A cascade synthesis, in vitro cholinesterases inhibitory activity and docking studies of novel Tacrine-pyranopyrazole derivatives.
Derabli C; Boualia I; Abdelwahab AB; Boulcina R; Bensouici C; Kirsch G; Debache A
Bioorg Med Chem Lett; 2018 Aug; 28(14):2481-2484. PubMed ID: 29887354
[TBL] [Abstract][Full Text] [Related]
25. Novel 1,3-Thiazole Analogues with Potent Activity against Breast Cancer: A Design, Synthesis, In Vitro, and In Silico Study.
Salem MG; El-Maaty DMA; El-Deen YIM; Elesawy BH; Askary AE; Saleh A; Saied EM; Behery ME
Molecules; 2022 Jul; 27(15):. PubMed ID: 35956848
[TBL] [Abstract][Full Text] [Related]
26. Chalcones bearing nitrogen-containing heterocyclics as multi-targeted inhibitors: Design, synthesis, biological evaluation and molecular docking studies.
Sıcak Y; Kekeçmuhammed H; Karaküçük-İyidoğan A; Taşkın-Tok T; Oruç-Emre EE; Öztürk M
J Mol Recognit; 2023 Jul; 36(7):e3020. PubMed ID: 37092742
[TBL] [Abstract][Full Text] [Related]
27. Design, synthesis, modeling studies and biological evaluation of pyrazole derivatives linked to oxime and nitrate moieties as nitric oxide donor selective COX-2 and aromatase inhibitors with dual anti-inflammatory and anti-neoplastic activities.
A A Fadaly W; A M M Elshaier Y; T M Nemr M; R A Abdellatif K
Bioorg Chem; 2023 May; 134():106428. PubMed ID: 36893546
[TBL] [Abstract][Full Text] [Related]
28. 4-Bromo-4'-chloro pyrazoline analog of curcumin augmented anticancer activity against human cervical cancer, HeLa cells:
Chaudhary M; Kumar N; Baldi A; Chandra R; Babu MA; Madan J
J Biomol Struct Dyn; 2020 Mar; 38(5):1335-1353. PubMed ID: 30957694
[TBL] [Abstract][Full Text] [Related]
29. Molecular docking, molecular dynamics, MM/PBSA approaches and bioactivity studies of nepetanudoside B isolated from endemic
Başar Y; Demirtaş İ; Yenigün S; İpek Y; Özen T; Behçet L
J Biomol Struct Dyn; 2024 Jan; ():1-14. PubMed ID: 38288959
[TBL] [Abstract][Full Text] [Related]
30. Design, synthesis, and biological evaluation of symmetrical azine derivatives as novel tyrosinase inhibitors.
Karimian S; Kazemi F; Attarroshan M; Gholampour M; Hemmati S; Sakhteman A; Behzadipour Y; Kabiri M; Iraji A; Khoshneviszadeh M
BMC Chem; 2021 Sep; 15(1):54. PubMed ID: 34587988
[TBL] [Abstract][Full Text] [Related]
31. Development of highly potent melanogenesis inhibitor by in vitro, in vivo and computational studies.
Abbas Q; Ashraf Z; Hassan M; Nadeem H; Latif M; Afzal S; Seo SY
Drug Des Devel Ther; 2017; 11():2029-2046. PubMed ID: 28740364
[TBL] [Abstract][Full Text] [Related]
32. Synthesis, computational studies, tyrosinase inhibitory kinetics and antimelanogenic activity of hydroxy substituted 2-[(4-acetylphenyl)amino]-2-oxoethyl derivatives.
Rafiq M; Nazir Y; Ashraf Z; Rafique H; Afzal S; Mumtaz A; Hassan M; Ali A; Afzal K; Yousuf MR; Saleem M; Kotwica-Mojzych K; Mojzych M
J Enzyme Inhib Med Chem; 2019 Dec; 34(1):1-11. PubMed ID: 31456445
[TBL] [Abstract][Full Text] [Related]
33. Synthesis and evaluation of novel arylisoxazoles linked to tacrine moiety: in vitro and in vivo biological activities against Alzheimer's disease.
Rastegari A; Safavi M; Vafadarnejad F; Najafi Z; Hariri R; Bukhari SNA; Iraji A; Edraki N; Firuzi O; Saeedi M; Mahdavi M; Akbarzadeh T
Mol Divers; 2022 Feb; 26(1):409-428. PubMed ID: 34273065
[TBL] [Abstract][Full Text] [Related]
34. Benzimidazolium salts bearing the trifluoromethyl group as organofluorine compounds: Synthesis, characterization, crystal structure, in silico study, and inhibitory profiles against acetylcholinesterase and α-glycosidase.
Tezcan B; Gök Y; Sevinçek R; Taslimi P; Taskin-Tok T; Aktaş A; Güzel B; Aygün M; Gülçin İ
J Biochem Mol Toxicol; 2022 Apr; 36(4):e23001. PubMed ID: 35225413
[TBL] [Abstract][Full Text] [Related]
35. Novel oxadiazole derivatives as potent inhibitors of α-amylase and α-glucosidase enzymes: Synthesis,
Bukhari A; Nadeem H; Imran M; Muhammad SA
Iran J Basic Med Sci; 2021 Dec; 24(12):1632-1642. PubMed ID: 35432813
[TBL] [Abstract][Full Text] [Related]
36. New 4-phenylpiperazine-carbodithioate-N-phenylacetamide hybrids: Synthesis, in vitro and in silico evaluations against cholinesterase and α-glucosidase enzymes.
Mohammadi-Khanaposhtani M; Nori M; Valizadeh Y; Javanshir S; Dastyafteh N; Moaazam A; Hosseini S; Larijani B; Adibi H; Biglar M; Hamedifar H; Mahdavi M; Kamci H; Karakus A; Taslimi P
Arch Pharm (Weinheim); 2022 May; 355(5):e2100313. PubMed ID: 35132681
[TBL] [Abstract][Full Text] [Related]
37. Synthesis and biological evaluation of substituted aurone derivatives as potential tyrosinase inhibitors:
Alshaye NA; Mughal EU; Elkaeed EB; Ashraf Z; Kehili S; Nazir Y; Naeem N; Abdul Majeed N; Sadiq A
J Biomol Struct Dyn; 2023; 41(17):8307-8322. PubMed ID: 36255179
[TBL] [Abstract][Full Text] [Related]
38. Novel Pyrazolo[3,4-d]pyrimidines as Potential Cytotoxic Agents: Design, Synthesis, Molecular Docking and CDK2 Inhibition.
Maher M; Kassab AE; Zaher AF; Mahmoud Z
Anticancer Agents Med Chem; 2019; 19(11):1368-1381. PubMed ID: 31038080
[TBL] [Abstract][Full Text] [Related]
39. Design, synthesis,
Saleem Naz Babari I; Islam M; Saeed H; Nadeem H; Imtiaz F; Ali A; Shafiq N; Alamri A; Zahid R; Ahmad I
J Biomol Struct Dyn; 2024 Feb; ():1-18. PubMed ID: 38351577
[TBL] [Abstract][Full Text] [Related]
40. Pharmacological evaluations of amide carboxylates as potential anti-Alzheimer agents: anti-radicals, enzyme inhibition, simulation and behavioral studies in animal models.
Mahnashi MH; Ali S; M Alshehri O; Almazni IA; Asiri SA; Sadiq A; Zafar R; Jan MS
J Biomol Struct Dyn; 2023 Aug; ():1-20. PubMed ID: 37642974
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
